National Cohort of Children Born to HIV-positive Mothers

NCT03306251 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5200

Last updated 2021-04-30

No results posted yet for this study

Summary

The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.

Conditions

  • Mother to Child Transmission of HIV

Sponsors & Collaborators

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Josiane WARSZAWSKI · CESP INSERM U1018

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • France
  • French Guiana
  • Guadeloupe
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306251 on ClinicalTrials.gov